Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/a-2156-5667
Longitudinal Digital Mood Charting in Bipolar Disorder: Experiences with ChronoRecord Over 20 Years
![](https://www.thieme-connect.de/media/pharmaco/202305/lookinside/thumbnails/2023-08-1206_10-1055-a-2156-5667-1.jpg)
Abstract
Introduction Longitudinal study is an essential methodology for understanding disease trajectories, treatment effects, symptom changes, and long-term outcomes of affective disorders. Daily self-charting of mood and other illness-related variables is a commonly recommended intervention. With the widespread acceptance of home computers in the early 2000s, automated tools were developed for patient mood charting, such as ChronoRecord, a software validated by patients with bipolar disorder. The purpose of this study was to summarize the daily mood, sleep, and medication data collected with ChronoRecord, and highlight some of the key research findings. Lessons learned from implementing a computerized tool for patient self-reporting are also discussed.
Methods After a brief training session, ChronoRecord software for daily mood charting was installed on a home computer and used by 609 patients with affective disorders.
Results The mean age of the patients was 40.3±11.8 years, a mean age of onset was 22±11.2 years, and 71.4% were female. Patients were euthymic for 70.8% of days, 15.1% had mild depression, 6.6% had severe depression, 6.6% had hypomania, and 0.8% had mania. Among all mood groups, 22.4% took 1–2 medications, 37.2% took 3–4 medications, 25.7 took 5–6 medications, 11.6% took 7–8 medications, and 3.1% took >8 medications.
Conclusion The daily mood charting tool is a useful tool for increasing patient involvement in their care, providing detailed patient data to the physician, and increasing understanding of the course of illness. Longitudinal data from patient mood charting was helpful in both clinical and research settings.
Publication History
Received: 07 August 2023
Received: 09 August 2023
Accepted: 09 August 2023
Article published online:
07 September 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 World Health Organization. World Health Organization Report – Depression and Other Common Mental Disorders: Global Health Estimates. 2017
- 2 Ferrari AJ, Charlson FJ, Norman RE. et al. Burden of depressive disorders by country, sex, age, and year: Findings from the global burden of disease study 2010. PLoS Med 2013; 10: e1001547
- 3 Proudman D, Greenberg P, Nellesen D. The growing burden of major depressive disorders (MDD): Implications for researchers and policy makers. Pharmacoeconomics 2021; 39: 619-625
- 4 Musliner KL, Munk-Olsen T, Laursen TM. et al. Heterogeneity in 10-year course trajectories of moderate to severe major depressive disorder. JAMA Psychiatry 2016; 73: 346-353
- 5 Solis EC, van Hemert AM, Carlier IVE. et al. The 9-year clinical course of depressive and anxiety disorders: New NESDA findings. J Affect Disord 2021; 295: 1269-1279
- 6 Sutin AR, Terracciano A, Milaneschi Y. et al. The trajectory of depressive symptoms across the adult life span. JAMA Psychiatry 2013; 70: 803-811
- 7 Bauer M, Andreassen OA, Geddes JR. et al. Areas of uncertainties and unmet needs in bipolar disorders: clinical and research perspectives. Lancet Psychiatr 2018; 5: 930-939
- 8 Solmi M, Radua J, Olivola M. et al. Age at onset of mental disorders worldwide: Large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry 2022; 27: 281-295
- 9 Monroe SM, Harkness KL. Major depression and its recurrences: Life course matters. Ann Rev Clin Psychol 2022; 18: 329-357
- 10 Vázquez GH, Holtzman JN, Lolich M. et al. Recurrence rates in bipolar disorder: Systematic comparison of long-term prospective, naturalistic studies versus randomized controlled trials. Eur Neuropsychopharmacol 2015; 25: 1501-1512
- 11 Vos T, Haby MM, Barendregt JJ. et al. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry 2004; 61: 1097-1103
- 12 Kessing LV, Andersen PK. Evidence for clinical progression of unipolar and bipolar disorders. Acta Psychiatr Scand 2017; 135: 51-64
- 13 Von Korff M, Gruman J, Schaefer J. et al. Collaborative management of chronic illness. Ann Intern Med 1997; 127: 1097-102
- 14 Weber MM, Engstrom EJ. Kraepelin's 'diagnostic cards': The confluence of clinical research and preconceived categories. Hist Psychiatry 1997; 8: 375-378
- 15 Kraepelin E. Psychiatrie. Ein Lehrbuch für Studierende und Ärzte. 8. Auflage 1909-1915. Leipzig; J.A: Barth; 1909
- 16 Morriss RK, Faizal MA, Jones AP. et al. Interventions for helping people recognise early signs of recurrence in bipolar disorder. Cochrane Database Syst Rev 2007; 2007: CD004854
- 17 Leverich GS, Nolen WA, Rush AJ. et al. The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. J Affect Disord 2001; 67: 33-44
- 18 Nierenberg AA, Ostacher MJ, Borrelli DJ. et al. The integration of measurement and management for the treatment of bipolar disorder: A STEP-BD model of collaborative care in psychiatry. J Clin Psychiatr 2006; 67: 3-7
- 19 Bauer MS, Crits-Christoph P, Ball WA. et al. Independent assessment of manic and depressive symptoms by self-rating. Scale characteristics and implications for the study of mania. Arch Gen Psychiatry 1991; 48: 807-812
- 20 Whybrow PC, Grof P, Gyulai L. et al. The electronic assessment of the longitudinal course of bipolar disorder: The ChronoRecord software. Pharmacopsychiatry 2003; 36: 244-249
- 21 Bauer M, Grof P, Gyulai L. et al. Using technology to improve longitudinal studies: Self-reporting in bipolar disorder. Bipolar Disord 2004; 6: 67-74
- 22 Bauer M, Wilson T, Neuhaus K. et al. Self-reporting software for bipolar disorder: Validation of ChronoRecord by patients with mania. Psychiatry Res 2008; 159: 359-336
- 23 Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62
- 24 Young RC, Biggs JT, Ziegler VE. et al. A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435
- 25 Judd LL, Akiskal HS, Schettler PJ. et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530-537
- 26 Bauer M, Grof P, Pfennig A. et al. Self-reported data from patients with bipolar disorder: Frequency of brief depression. J Affect Disorders 2007; 101: 227-233
- 27 Bauer M, Glenn T, Keil M. et al. Brief depressive symptoms in patients with bipolar disorder: Analysis of long-term self-reported data. Aust N Z J Psychiatry 2012; 46: 1068-1078
- 28 Bauer M, Glenn T, Rasgon N. et al. Decreasing the minimum length criterion for an episode of hypomania: Evaluation using self-reported data from patients with bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2011; 261: 341-347
- 29 Bauer M, Glenn T, Grof P. et al. Frequency of subsyndromal symptoms and employment status in patients with bipolar disorder. Soc Psychiatry Psychiatr Epidemiol 2009; 44: 515-522
- 30 Altshuler LL, Post RM, Black DO. et al. Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: Results of a large, multisite study. J Clin Psychiatr 2006; 67: 1551-1560
- 31 Bauer M, Glenn T, Grof P. et al. Comparison of sleep/wake parameters for self-monitoring bipolar disorder. J Affect Disord 2009; 116: 170-175
- 32 Bauer M, Grof P, Rasgon N. et al. Temporal relation between sleep and mood in patients with bipolar disorder. Bipolar Disord 2006; 8: 160-167
- 33 Bauer M, Glenn T, Whybrow PC. et al. Changes in self-reported sleep duration predict mood changes in bipolar disorder. Psychol Med 2008; 38: 1069-1071
- 34 Bauer M, Glenn T, Alda M. et al. Comparison of pre-episode and pre-remission states using mood ratings from patients with bipolar disorder. Pharmacopsychiatry 2011; 44: 49-53
- 35 Bauer M, Glenn T, Alda M. et al. Drug treatment patterns in bipolar disorder: Analysis of long-term self-reported data. Int J Bipolar Disord 2013; 1: 5
- 36 Bauer M, Glenn T, Alda M. et al. Association between adherence with an atypical antipsychotic and with other psychiatric drugs in patients with bipolar disorder. Pharmacopsychiatry 2021; 54: 75-80
- 37 Bauer M, Glenn T, Alda M. et al. Trajectories of adherence to mood stabilizers in patients with bipolar disorder. Int J Bipolar Disord 2019; 7: 19
- 38 Bauer M, Glenn T, Alda M. et al. Regularity in daily mood stabilizer dosage taken by patients with bipolar disorder. Pharmacopsychiatry 2013; 46: 163-168
- 39 Pilhatsch M, Glenn T, Rasgon N. et al. Regularity of self-reported daily dosage of mood stabilizers and antipsychotics in patients with bipolar disorder. Int J Bipolar Disord 2018; 6: 10